Coronavirus (COVID-19) mRNA vaccine (Walvax Biotechnology)

新型冠状病毒(COVID-19)mRNA疫苗（沃森生物）

Report date: 2022/12/05 17:33:39

Base Information

Drug NameCoronavirus (COVID-19) mRNA vaccine (Walvax Biotechnology)
Drug Alias NameARCoV新型冠状病毒mRNA疫苗 (苏州艾博生物)ARCoVaXAWcorna沃艾可欣 +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndonesia
Original Approved Date2022/09/30
Country/TerritoryMexicoIndonesiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWalvax Biotechnology Co LtdAcademy Of Military Medical SciencesAbogen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jinsirui Vigorous Biotechnology Co LtdAbogen Biosciences Co LtdWalvax Biotechnology Co Ltd
Inactive CompaniesYuxi Walvax Biotechnology Co Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A